Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huandi Zhou

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Oncology|December 6, 2022
A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 GliomaQi Gao, Huandi Zhou, Guohui Wang, et al.
Scientific Reports|November 11, 2023
IDH1<sup>R132H</sup> mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomasXuetao Han, Huandi Zhou, Wei Sun, et al.
Frontiers in Surgery|June 19, 2025
Pleomorphic xanthoastrocytoma with multiple recurrences and continuous malignant progression to bone metastasis: a case reportLei Tian, Wei Sun, Lei Lou, et al.
Journal of Medical Imaging and Radiation Oncology|June 11, 2025
Exploration of Diffusion Tensor Imaging for Delineating Target Volume Boundary in Glioblastoma RadiotherapyLei Tian, Wenyan Wang, Wei Sun, et al.
Journal of Cancer|November 8, 2024
Identification of an Immune signature assisted prognosis, and immunotherapy prediction for IDH wildtype glioblastomaXuetao Han, Huandi Zhou, Xiaohui Ge, et al.
The Journal of International Medical Research|March 26, 2026
Efficacy of radiotherapy combined with immunotherapy in driver gene-negative non-small cell lung cancer with brain metastases: A single-center retrospective analysisZizhou Zhang, Jiayuan Li, Huandi Zhou, et al.
Translational Oncology|May 10, 2024
HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathwayWei Han, Huandi Zhou, Xinyuan Zhang, et al.
Oncology Reports|January 16, 2026
<p>CDK1 depletion suppresses glioma malignancy through cell cycle pathway regulation: Mechanistic insights from functional and molecular profiling</p>Yu Wang, Huandi Zhou, Xuetao Han, et al.
Peerj|October 7, 2021
DNMT family induces down-regulation of NDRG1 <i>via</i> DNA methylation and clinicopathological significance in gastric cancerXiaojing Chang, Jinguo Ma, Xiaoying Xue, et al.
Technology in Cancer Research & Treatment|January 8, 2026
ACOSA: A Script-Based Algorithm for Multi-Disease Target Crop and Optimization in RadiotherapyHan Guo, Zhiqing Xiao, Huandi Zhou, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Oncology|December 6, 2022
A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 GliomaQi Gao, Huandi Zhou, Guohui Wang, et al.
Scientific Reports|November 11, 2023
IDH1<sup>R132H</sup> mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomasXuetao Han, Huandi Zhou, Wei Sun, et al.
Frontiers in Surgery|June 19, 2025
Pleomorphic xanthoastrocytoma with multiple recurrences and continuous malignant progression to bone metastasis: a case reportLei Tian, Wei Sun, Lei Lou, et al.
Journal of Medical Imaging and Radiation Oncology|June 11, 2025
Exploration of Diffusion Tensor Imaging for Delineating Target Volume Boundary in Glioblastoma RadiotherapyLei Tian, Wenyan Wang, Wei Sun, et al.
Journal of Cancer|November 8, 2024
Identification of an Immune signature assisted prognosis, and immunotherapy prediction for IDH wildtype glioblastomaXuetao Han, Huandi Zhou, Xiaohui Ge, et al.
The Journal of International Medical Research|March 26, 2026
Efficacy of radiotherapy combined with immunotherapy in driver gene-negative non-small cell lung cancer with brain metastases: A single-center retrospective analysisZizhou Zhang, Jiayuan Li, Huandi Zhou, et al.
Translational Oncology|May 10, 2024
HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathwayWei Han, Huandi Zhou, Xinyuan Zhang, et al.
Oncology Reports|January 16, 2026
<p>CDK1 depletion suppresses glioma malignancy through cell cycle pathway regulation: Mechanistic insights from functional and molecular profiling</p>Yu Wang, Huandi Zhou, Xuetao Han, et al.
Peerj|October 7, 2021
DNMT family induces down-regulation of NDRG1 <i>via</i> DNA methylation and clinicopathological significance in gastric cancerXiaojing Chang, Jinguo Ma, Xiaoying Xue, et al.
Technology in Cancer Research & Treatment|January 8, 2026
ACOSA: A Script-Based Algorithm for Multi-Disease Target Crop and Optimization in RadiotherapyHan Guo, Zhiqing Xiao, Huandi Zhou, et al.
Pageof 6